These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19535912)

  • 21. Dengue vaccine: reliably determining previous exposure.
    Ariën KK; Wilder-Smith A
    Lancet Glob Health; 2018 Aug; 6(8):e830-e831. PubMed ID: 29941282
    [No Abstract]   [Full Text] [Related]  

  • 22. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.
    Liu G; Song L; Beasley DW; Putnak R; Parent J; Misczak J; Li H; Reiserova L; Liu X; Tian H; Liu W; Labonte D; Duan L; Kim Y; Travalent L; Wigington D; Weaver B; Tussey L
    Clin Vaccine Immunol; 2015 May; 22(5):516-25. PubMed ID: 25761459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dengue vaccine: opportunities and challenges.
    Hatch S; Mathew A; Rothman A
    IDrugs; 2008 Jan; 11(1):42-5. PubMed ID: 18175262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.
    Lazo L; Hermida L; Zulueta A; Sánchez J; López C; Silva R; Guillén G; Guzmán MG
    Vaccine; 2007 Jan; 25(6):1064-70. PubMed ID: 17097199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
    Valdés I; Lazo L; Hermida L; Guillén G; Gil L
    Front Immunol; 2019; 10():1956. PubMed ID: 31507591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice.
    Zheng X; Chen H; Wang R; Fan D; Feng K; Gao N; An J
    Front Cell Infect Microbiol; 2017; 7():175. PubMed ID: 28553618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
    Normile D
    Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
    [No Abstract]   [Full Text] [Related]  

  • 29. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.
    Gil L; Martín A; Lazo L
    Front Immunol; 2019; 10():2946. PubMed ID: 31921194
    [No Abstract]   [Full Text] [Related]  

  • 31. Mosquito control might not bolster imperfect dengue vaccines.
    Paul R; Sousa C; Sakuntabhai A; Devine G
    Lancet; 2014 Nov; 384(9956):1747-8. PubMed ID: 25455246
    [No Abstract]   [Full Text] [Related]  

  • 32. Dengue: Status of current and under-development vaccines.
    Redoni M; Yacoub S; Rivino L; Giacobbe DR; Luzzati R; Di Bella S
    Rev Med Virol; 2020 Jul; 30(4):e2101. PubMed ID: 32101634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dengue vaccines: state of the art.
    Swaminathan S; Batra G; Khanna N
    Expert Opin Ther Pat; 2010 Jun; 20(6):819-35. PubMed ID: 20384534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Sanofi Pasteur tetravalent dengue vaccine.
    Lang J
    Rev Inst Med Trop Sao Paulo; 2012 Oct; 54 Suppl 18():S15-7. PubMed ID: 23011454
    [No Abstract]   [Full Text] [Related]  

  • 36. Vaccination Against Dengue: Challenges and Current Developments.
    Guy B; Lang J; Saville M; Jackson N
    Annu Rev Med; 2016; 67():387-404. PubMed ID: 26515983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.
    Huang X; Karabudak A; Comber JD; Philip M; Morcol T; Philip R
    Hum Vaccin Immunother; 2017 Nov; 13(11):2612-2625. PubMed ID: 28933657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines and immunization strategies for dengue prevention.
    Liu Y; Liu J; Cheng G
    Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.
    Gil L; Izquierdo A; Lazo L; Valdés I; Ambala P; Ochola L; Marcos E; Suzarte E; Kariuki T; Guzmán G; Guillén G; Hermida L
    Virology; 2014 May; 456-457():70-6. PubMed ID: 24889226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue vaccine: WHO position paper – July 2016.
    Wkly Epidemiol Rec; 2016 Jul; 91(30):349-64. PubMed ID: 27476189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.